ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes

Table 1 E74-like ETS transcription factor 3 and clinicopathological characteristics of gastric cancer patients (n = 100)

Variable		ELF3 expression		P value
		Low (52)	High (48)
Age (years)	< 60	18	15	0.724
	≥ 60	34	33
Gender	Male	35	29	0.478
	Female	17	19
Tumor size (cm)	< 5	31	17	0.015
	≥ 5	21	31
T stage	T1 + T2	18	4	0.090
	T3 + T4	34	42
N stage	N0 + N1	28	15	0.023
	N2 + N3	24	33
TNM stage	I + II	30	15	0.008
	III + IV	22	33
Ki-67	Low	30	20	0.001
	High	22	28
E-cadherin	Low	20	29	0.028
	High	32	19

ELF3: E74-like ETS transcription factor 3; TNM: Tumor-node-metastasis.